Limbal autograft and allograft transplantations in patients with corneal burns.
OBJECTIVE
To investigate and compare the surgical outcomes of limbal autograft and limbal allograft transplantations in patients with corneal burns.


METHODS
In total, 20 patients (n=22 eyes) with chemical burn and two patients (n=2 eyes) with thermal burn were included in this study. Limbal autograft or limbal allograft transplantation surgery was performed in all patients. HLA-typing was tested before allograft surgeries. Limbal allografting was performed in all eyes using donor tissue from live relatives. Systemic cyclosporine A was administered for immunosuppression.


RESULTS
The corneal surface was successfully reconstructed in all eyes (100%) after limbal autografting, two eyes required additional amniotic membrane transplantation and one eye required allografting. The mean follow-up period for limbal autografts was 13.9 +/- 7.0 months. Limbal allografting failed to reduce corneal vascularity and opacification in five (55.6%) eyes and was successful only in four (44.4%) eyes (mean follow-up 16.2 +/- 11.2 months) (P=0.002). In all, 15 eyes undergoing limbal autografting completed re-epithelialization of the cornea at a mean of 35.6 +/- 60.2 days. The mean epithelial healing time in nine eyes undergoing limbal allografting was 13.0 +/- 7.3 days (P=0.525). After limbal autografting, functional vision (> or =1/10) was attained in 12 (80%) eyes. Only one eye (11.1%) achieved functional vision after limbal allografting (P=0.036). Penetrating keratoplasty was performed in three patients following limbal allografting. No cyclosporine-associated side effects were observed.


CONCLUSIONS
Limbal autograft transplantation is an effective and safe procedure for unilateral corneal burns. It seems that limbal allograft transplantation is better combined with penetrating keratoplasty for a better visual outcome and higher graft survival rate. Systemic immunosuppression seems to be necessary for limbal allografts even in the presence of HLA-matched donor tissues.
Ozdemir
O
O
Department of Ophthalmology, Ankara University School of Medicine, Turkey.
Tekeli
O
O
Ornek
K
K
Arslanpençe
A
A
Yalçindağ
N F
NF
D000293:Adolescent; D000328:Adult; D000368:Aged; D002057:Burns, Chemical / Q000503:physiopathology / Q000601:surgery*; D002675:Child, Preschool; D065306:Corneal Injuries; D016039:Corneal Transplantation / Q000379:methods*; D016572:Cyclosporine / Q000627:therapeutic use; D005126:Eye Burns / Q000139:chemically induced / Q000601:surgery*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012086:Reoperation; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology; D014945:Wound Healing / Q000502:physiology
D007166:Immunosuppressive Agents; D016572:Cyclosporine